Literature DB >> 11018256

Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues.

A Chlenski1, K V Ketels, G I Korovaitseva, M S Talamonti, R Oyasu, D G Scarpelli.   

Abstract

One of the tight junction components, zonula occludens protein 2 (ZO-2), is expressed as two isoforms, ZO-2A and ZO-2C, in normal epithelia. In pancreatic adenocarcinoma of the ductal type ZO-2A is absent, but none of the common mechanisms of gene inactivation is responsible for lack of ZO-2A expression. In the current study, we report the complete organization of the human zo-2 gene (tjp-2), its alternative splicing, and its expression in normal and neoplastic tissues of several organ sites. In addition to pancreatic adenocarcinoma, ZO-2 was found to be de-regulated in breast adenocarcinoma, but not in colon or prostate adenocarcinoma. The latter are considered to be of acinar rather than ductal type. Thus, our data indicate the importance of zo-2 (tjp-2) gene regulation in ductal cancer development and should help to understand the defects of intercellular interactions, critical for suppressing the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018256     DOI: 10.1016/s0167-4781(00)00185-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

Review 1.  The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis.

Authors:  Masahiko Itoh; Mina J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

2.  Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells.

Authors:  Elizabeth McNeil; Christopher T Capaldo; Ian G Macara
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

3.  Mutations in TJP2 cause progressive cholestatic liver disease.

Authors:  Melissa Sambrotta; Sandra Strautnieks; Efterpi Papouli; Peter Rushton; Barnaby E Clark; David A Parry; Clare V Logan; Lucy J Newbury; Binita M Kamath; Simon Ling; Tassos Grammatikopoulos; Bart E Wagner; John C Magee; Ronald J Sokol; Giorgina Mieli-Vergani; Joshua D Smith; Colin A Johnson; Patricia McClean; Michael A Simpson; A S Knisely; Laura N Bull; Richard J Thompson
Journal:  Nat Genet       Date:  2014-03-09       Impact factor: 38.330

Review 4.  Polarity proteins as regulators of cell junction complexes: implications for breast cancer.

Authors:  Dana Bazzoun; Sophie Lelièvre; Rabih Talhouk
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

5.  Zona occludens-2 inhibits cyclin D1 expression and cell proliferation and exhibits changes in localization along the cell cycle.

Authors:  Rocio Tapia; Miriam Huerta; Socorro Islas; Antonia Avila-Flores; Esther Lopez-Bayghen; Jörg Weiske; Otmar Huber; Lorenza González-Mariscal
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

Review 6.  The dual role of zonula occludens (ZO) proteins.

Authors:  H Bauer; J Zweimueller-Mayer; P Steinbacher; A Lametschwandtner; H C Bauer
Journal:  J Biomed Biotechnol       Date:  2010-03-09

Review 7.  Regulation of actin dynamics and protein trafficking during spermatogenesis--insights into a complex process.

Authors:  Wenhui Su; Dolores D Mruk; C Yan Cheng
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-01-23       Impact factor: 8.250

8.  Ontogeny and the effects of exogenous and endogenous glucocorticoids on tight junction protein expression in ovine cerebral cortices.

Authors:  Anna R Duncan; Grazyna B Sadowska; Barbara S Stonestreet
Journal:  Brain Res       Date:  2009-09-26       Impact factor: 3.252

9.  Regulation of membrane-type 1 matrix metalloproteinase expression by zonula occludens-2 in human lung cancer cells.

Authors:  E Luczka; L Syne; B Nawrocki-Raby; C Kileztky; W Hunziker; P Birembaut; C Gilles; Myriam Polette
Journal:  Clin Exp Metastasis       Date:  2013-04-21       Impact factor: 5.150

10.  Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

Authors:  Vaibhav P Pai; Aaron M Marshall; Laura L Hernandez; Arthur R Buckley; Nelson D Horseman
Journal:  Breast Cancer Res       Date:  2009-11-10       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.